Panel session focusing on 'Showcasing UK Leadership & International Opportunities' in Lifescience at the Global Investment Conference at the British Business Embassy on 26th July 2012. Speakers and panel members include:
Chair: Sir Andrew Witty, CEO, GlaxoSmithKline
Prof. Dame Sally Davies, UK Chief Medical Officer and Chief Scientific Adviser for the Department of Health
Sir Mark Walport, Director, Wellcome Trust
Sir Paul Nurse, Director, Francis Crick Institute
Kate Bingham, Managing Partner, SV Life Sciences Advisers LLP
